Non-iodinated contrast media

I. Introduction

Non-iodinated contrast media are a class of contrast agents used in various imaging modalities to enhance the visibility of anatomical structures or physiological functions without containing iodine, which is the most commonly used radiopaque element in contrast-enhanced imaging. These agents are especially important for patients with iodine allergies, renal impairment, or where specific tissue or functional imaging is required, such as in magnetic resonance imaging (MRI) or ultrasound-based techniques.

Non-iodinated contrast media are categorized based on the modality of imaging, chemical composition, and mechanism of enhancement. The most widely used types are gadolinium-based contrast agents (GBCAs) for MRI and microbubble contrast agents for ultrasound imaging. In addition, certain barium-based and carbon dioxide (CO₂) agents are used for specific radiologic procedures.

---

II. Classification of Non-Iodinated Contrast Media

Non-iodinated contrast agents can be classified as follows:

A. Magnetic Resonance Imaging (MRI) Contrast Agents

1. Gadolinium-Based Contrast Agents (GBCAs)

2. Iron Oxide Nanoparticles

3. Manganese-Based Agents

4. Fluorine-Based Agents (experimental)

B. Ultrasound Contrast Agents

1. Microbubble-Based Agents (gas-filled)

   • E.g., perflutren lipid microspheres

C. Radiographic and Fluoroscopic Agents

1. Barium Sulfate Suspensions

2. Carbon Dioxide (CO₂) (as a negative contrast agent)

---

III. Gadolinium-Based Contrast Agents (GBCAs)

A. Introduction

GBCAs are the most commonly used non-iodinated contrast agents, primarily employed in MRI to enhance visualization of:

• Blood vessels (MR angiography)

• Tumors

• Inflammatory processes

• Neurologic structures

B. Mechanism of Action

Gadolinium (Gd³⁺) is a rare earth metal with paramagnetic properties, which shortens the T1 relaxation time of tissues in MRI, resulting in bright signal intensity on T1-weighted images.

However, free gadolinium is toxic, so it is chelated to organic ligands to reduce toxicity and improve safety.

C. Types of GBCAs

1. Linear Agents (less stable; higher risk of gadolinium release)

   • Gadodiamide (Omniscan®)

   • Gadopentetate dimeglumine (Magnevist®)

2. Macrocyclic Agents (more stable; lower risk of dissociation)

   • Gadoterate meglumine (Dotarem®)

   • Gadobutrol (Gadavist®)

   • Gadoteridol (ProHance®)

3. Protein-binding Agents

   • Gadofosveset trisodium (Ablavar®) – withdrawn from market

D. Clinical Applications

• CNS imaging (brain tumors, multiple sclerosis)

• MR angiography (aorta, renal arteries)

• Musculoskeletal imaging

• Cardiac MRI (myocardial perfusion and fibrosis)

E. Safety Profile and Adverse Effects

1. Acute Reactions

• Nausea, headache, dizziness, mild rash

• Anaphylactoid reactions (rare)

2. Nephrogenic Systemic Fibrosis (NSF)

• Serious complication in patients with severe renal impairment

• Primarily linked to linear GBCAs

3. Gadolinium Retention

• Small amounts may deposit in brain and tissues

• Clinical significance under investigation

• Macrocyclic agents have lower retention

---

IV. Iron-Based Contrast Agents

Iron oxide nanoparticles are superparamagnetic agents used primarily for T2-weighted MRI.

Examples:

• Ferumoxytol (Feraheme®): Also approved for iron replacement therapy

• Ferumoxtran-10 (experimental)

Clinical Use:

• Liver and spleen imaging

• Lymph node imaging

• Vascular imaging in patients with gadolinium contraindications

Safety:

• Lower risk of NSF

• Can interfere with iron tests

• Risk of hypersensitivity reactions

---

V. Manganese-Based MRI Contrast Agents

• Manganese (Mn²⁺) is paramagnetic and shortens T1 relaxation time

• Experimental agents include manganese dipyridoxyl diphosphate (MnDPDP)

Potential Use:

• Liver-specific imaging

• Cardiac viability imaging

Status:

• Withdrawn from many markets; being re-evaluated for safety and targeted delivery systems

---

VI. Fluorine-Based MRI Contrast Agents (Experimental)

• Use 19F MRI instead of hydrogen (1H)

• Advantage: No background fluorine signal in the body

• Allows for quantitative imaging of labeled cells or contrast agents

Still under research and development; not in routine clinical use.

---

VII. Microbubble Contrast Agents for Ultrasound

Microbubbles are gas-filled microspheres, typically composed of:

• Shell: phospholipid, albumin, or polymer

• Gas core: perfluorocarbon or nitrogen

Examples:

• Definity® (perflutren lipid microsphere)

• Optison® (perflutren protein type-A microsphere)

• Lumason® / SonoVue® (sulfur hexafluoride microbubbles)

Mechanism:

• Enhance echogenicity of blood and perfused tissues due to acoustic impedance mismatch

• Used in contrast-enhanced ultrasound (CEUS)

Indications:

• Echocardiography (endocardial border definition)

• Liver lesion characterization

• Renal perfusion

• Vesicoureteral reflux assessment (pediatric)

Safety:

• Well tolerated

• Avoid in patients with right-to-left shunt, pulmonary hypertension, or unstable cardiopulmonary status

---

VIII. Barium Sulfate Suspensions

• Non-iodinated, radio-opaque substance

• Inert and insoluble in water

• Used only in GI tract imaging under fluoroscopy or X-ray

Applications:

• Barium swallow, meal, enema

• Used to outline esophagus, stomach, small intestine, and colon

Advantages:

• High contrast and mucosal coating

• Inexpensive and effective

Limitations:

• Cannot be used if perforation is suspected

• Contraindicated in aspiration risk

• Alternative: water-soluble iodinated agents in suspected perforation

---

IX. Carbon Dioxide (CO₂) as Contrast

• Radiolucent gas used as a negative contrast agent

• Displaces blood in vessels, creating contrast in digital subtraction angiography (DSA)

Uses:

• Vascular imaging in patients with renal failure or iodine allergy

• Preferred in infra-diaphragmatic arteries (e.g., lower limb angiography)

Advantages:

• Non-nephrotoxic

• Inexpensive

Disadvantages:

• Limited to venous and infra-diaphragmatic arteries

• Risk of air embolism, especially above the diaphragm

• Poor visualization of small vessels

---

X. Comparison: Non-Iodinated vs Iodinated Contrast Media

Feature	Non-Iodinated Agents	Iodinated Contrast Media
Imaging modality	MRI, ultrasound, fluoroscopy (GI), angiography	X-ray, CT, angiography
Contains iodine	No	Yes
Nephrotoxicity	Lower (except GBCAs in severe CKD)	Higher
Anaphylactoid risk	Very low	Moderate
Use in iodine allergy	Safe	Contraindicated
Mechanism	Paramagnetic (MRI), acoustic, inert fillers	X-ray attenuation

XI. Special Considerations

1. Pregnancy and Lactation

• Gadolinium crosses the placenta and is category C; use only when necessary

• GBCAs appear in breast milk in negligible amounts — breastfeeding can continue

2. Pediatric Use

• Approved doses and safety profiles available for select GBCAs and microbubble agents

• Careful dose calculation required

3. Renal Impairment

• Avoid linear GBCAs; prefer macrocyclic agents

• Ferumoxytol and CO₂ may be considered alternatives

---

XII. Future Directions and Research

• Molecular imaging contrast agents (target-specific)

• Theranostic agents combining imaging and therapy

• Smart contrast agents (responsive to pH, enzymes, etc.)

• Gadolinium-free MRI agents (iron, manganese, fluorine)

---

XIII. Summary of Common Non-Iodinated Contrast Agents

Agent Type	Examples	Imaging Modality	Notes
Gadolinium chelates	Gadobutrol, Gadoterate	MRI	Most common
Microbubbles	Definity, Lumason	Ultrasound	Cardiovascular and liver imaging
Barium sulfate	Baritop, E-Z-HD	GI X-ray/fluoro	Oral/rectal use only
CO₂ gas	Medical CO₂	DSA	Intra-arterial/venous imaging
Iron oxide	Ferumoxytol	MRI	Off-label use
Manganese-based	MnDPDP (experimental)	MRI	Being researched